2H-Pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-9-carboxylic acid, 11-cyclopropyl-6-fluoro-1,3,4,8,11,13,14,14a-octahydro-8-oxo- (1271982-15-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 11H-Pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-4,11-dicarboxylic acid, 6-cyclopropyl-1-fluoro-3,6,8,9,9a,10,12,13-octahydro-3-oxo-, 11-(1,1-dimethylethyl) 4-ethyl ester
- 1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
- 1/C12H24O2Te/c1-14-12(13)10-8-6-4-3-5-7-9-11-15-2/h3-11H2,1-2H
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- 1/C12H13NO/c1-10-12(14-2)8-9-13(10)11-6-4-3-5-7-11/h3-9H,1-2H
- 1/C12H16BrIO2/c1-3-5-15-11-8-10(14)12(7-9(11)13)16-6-4-2/h7-8H,3-6H2,1-2H
- 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
- 1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C13H10O/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13-14
- 1/C12H13NO/c1-2-4-10(5-3-1)13-11-6-8-12(14-13)9-7-11/h1-6,8,11-12H,7,9H
- 1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- 1/C7H10N3O3P/c1-4-7-13-9-5(2)14(7,12)10(8-4)6(3)11/h7H,1-3H
- 1/C13H19NO2/c1-9(15)6-7-10-8-13(16-14-10)11-4-2-3-5-12(11)13/h11-12H,2-8H2,1H
- 1/C10H10O5/c1-14-9(12)6-3-7(10(13)15-2)5-8(11)4-6/h3-5,11H,1-2H
- 1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
- 1/C10H10N2OS/c1-7-5-9(6-13)8(2)12(7)10-11-3-4-14-10/h3-6H,1-2H
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 1/C12H11NO4/c1-6-10(15)7-3-4-13-8(5-14)9(7)11(16)12(6)17-2/h3-4,14H,5H2,1-2H